TMT Fusion Plate vs. Two Crossed Screws (TMT)

TMT Fusion Plate vs. Two Crossed Screws - A Randomized Controlled Trial

This study will compare TMT Fusion Plate versus two crossed screws for the fixation of first tarsometatarsal joint arthrodesis. Patients who meet eligibility criteria will be randomly assigned to one of these two treatment options.

Study Overview

Detailed Description

Tarsometatarsal joint arthrodesis is a common procedure which can be performed using various devices such as screws, plates or both. The Tarsometatarsal Fusion Plate from "DePuySynthes" is a new device designed to encourage bony fusion of the 1st TMT joint, and is expected to lead to earlier fusion compared to the current standard of care of using 2 crossed screws. This is expected, in turn, to result in an earlier reduction in pain and an earlier return to full activity. At this time there is insufficient data directly comparing outcome following surgery for patients treated with screws or plates, and a study protocol which produces a higher level of evidence is therefore necessary.

The main aim of this study is to compare patient-reported outcome following surgery for patients undergoing joint arthrodesis using the TMT Fusion plate versus screws only. It is expected that surgery will improve patient-reported outcome similarly for both treatment groups in the long-term, but that the improvement will occur earlier for the plate group. For this study patient-reported outcome will be assessed by the walking/standing and pain domain scores of the Manchester Oxford Foot Questionnaire (MOXFQ). An earlier improvement in any of these two domains would be considered to be valuable. The primary analysis will therefore compare the time to a minimal clinically relevant improvement for any of the two MOXFQ domains for patients treated with TMT fusion plate versus patients treated with only screws during the first 12 months following surgery.

An economic evaluation from a societal perspective will determine the incremental cost-effectiveness of the TMT fusion plate versus the 2 crossed screws technique for 1st TMT joint fusion. Therefore a randomized controlled trial will be conducted, where patient-reported outcomes as well as clinical outcome parameters will be assessed.

Study Type

Interventional

Enrollment (Actual)

12

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Cali, Colombia, 233
        • Centro Médico Imbanaco Cali
      • Bristol, United Kingdom, BS10 5NB
        • Ian Winson
    • Michigan
      • East Lansing, Michigan, United States, 48823
        • Mid Michigan Orthopedic Institute - East Lansing
    • Minnesota
      • Woodbury, Minnesota, United States, 55125
        • Summit Orthopedics
    • New York
      • New York, New York, United States, 10038
        • NY Downtown Orthopedic Associates

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Age: between 18 and 65 years
  • At least one of the following:

    • 1st TMT arthritis
    • hallux valgus (intermetatarsal angle (IM) 1-2 angle > 15° on plain x-ray)
    • 1st ray hypermobility with or without flat foot
  • Painful condition
  • Ability to understand the content of the patient information / Informed Consent Form
  • Willingness and ability to participate in the clinical investigation according to the Clinical Investigation Plan (CIP)
  • Signed and dated IRB/EC-approved written informed consent

Exclusion Criteria:

  • Active infection
  • Previous surgery on the 1st ray of the same foot
  • Previous non-union on the 1st ray of the same foot
  • Clinical obvious arthritis in other joints of the lower extremities
  • Purely seeking plastic surgery
  • Peripheral vascular disease (e.g. advanced diabetes)
  • Peripheral sensory neuropathy (e.g. advanced diabetes)
  • Concurrent surgery of the contralateral foot
  • Any previously medically unmanaged severe systemic disease
  • Substance abuse that would preclude reliable assessment
  • Prisoner
  • Participation in any other medical device or medicinal product study within the previous month that could influence the results of the present study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: TMT Fusion Plate
Patients are treated with TMT Fusion Plate to encourage bony fusion of the 1st TMT joint.
Patients are treated with TMT Fusion Plate a post-market device to encourage bony fusion of the 1st TMT joint.
Other: Two crossed screws
Patients are treated with two crossed screws.This procedure is a standard treatment for 1st TMT joint fusion .
Patients are treated with two crossed screws.This procedure is a standard treatment for 1st TMT joint fusion.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in the patient-reported MOXFQ
Time Frame: Up to 4 weeks pre-operative, Discharge (up to 1 week post-operative), 2 week FU, 6 week FU, 3 month FU, 6 month FU, 12 month FU
Outcome measures for the study focus on fully validated patient related outcome measures for the foot (MOXFQ).
Up to 4 weeks pre-operative, Discharge (up to 1 week post-operative), 2 week FU, 6 week FU, 3 month FU, 6 month FU, 12 month FU

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Development of bone healing assessed based on x-rays
Time Frame: 6 and 12 weeks postoperative
6 and 12 weeks postoperative
Reconstruction of the joint position based on x-rays
Time Frame: Pre-operative up to 4 weeks vs. post-operative up to 2 weeks
Pre-operative up to 4 weeks vs. post-operative up to 2 weeks
Change in quality of life (EQ-5D)
Time Frame: Up to 4 weeks pre-operative, discharge (up to 1 week post-op), 2 weeks FU, 6 weeks FU, 3 months FU, 6 months FU, 12 months FU
Outcome measure of general health
Up to 4 weeks pre-operative, discharge (up to 1 week post-op), 2 weeks FU, 6 weeks FU, 3 months FU, 6 months FU, 12 months FU
Weekly assessed weight bearing during weeks 6-12
Time Frame: 3 months FU
3 months FU
Complications related to implant or surgery
Time Frame: Starts with surgery and is continued until the end of the study (12 months FU)
For the duration of the study complications are continuously recorded and not restricted to the defined follow up visits.
Starts with surgery and is continued until the end of the study (12 months FU)
Documentation of medication and treatment costs
Time Frame: Starts after surgery and is continued until the end of the study (12 months FU)
A cost diary to collect treatment costs is distributed and collected at the next FU visit.
Starts after surgery and is continued until the end of the study (12 months FU)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Ian Winson, MB ChB, FRCS, Southmead Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

October 1, 2014

Primary Completion (Actual)

August 1, 2016

Study Completion (Actual)

August 1, 2016

Study Registration Dates

First Submitted

March 21, 2014

First Submitted That Met QC Criteria

March 24, 2014

First Posted (Estimate)

March 26, 2014

Study Record Updates

Last Update Posted (Actual)

August 13, 2020

Last Update Submitted That Met QC Criteria

August 11, 2020

Last Verified

August 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • TMT Fusion Plate

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Clinical Indication for First Metatarsal Joint Arthrodesis

Clinical Trials on TMT Fusion plate

3
Subscribe